The program for the Business Day will feature CEOs, government leaders and experts from around the globe, addressing a variety of issues in plenary sessions, industry sector discussions and issue-specific forums.
The workshop commenced with plenary presentations by speakers from the FDA, industry, and academia.
The PAG meeting covers a very broad range of data exchange through many workshops and industry exhibitions, and the invited plenary lectures within a particular domain provide a particularly good snapshot of areas that are exciting and have relevance across the broader plant and animal disciplines.
Getting a handle on an overwhelming conference program is an art in itself, in particular if you attend a large conference with plenary lectures, parallel sessions, multiple poster sessions, and industry booths.
It consisted of plenary presentations from researchers, local urban decision-makers and industry, discussions, and student group work with the final goal to develop smart sustainable strategies for a new residential district in Shanghai.
The second plenary lecture reported on the economic loss to the pig industry in Taiwan brought about by diseases such as foot and mouth disease and circovirus infection.
Representatives from industry, academia, and regulatory agencies discussed the issues within plenary and panel discussions.
The business and industry major group did make oral commitments at the WCDRR plenary session in support of standardization and certification, the resilient cities initiative, and risk financing, but no clear action points exist to guide work toward specific goals.
Approximately 50 participants drawn nearly equally from faculty members, university administrators, postdocs, and representatives of industry, government agencies, and professional associations joined with key NSF staffers in plenary sessions and breakout groups.
The plenary sessions offered three perspectives: FDA (presented by Dr. Ping Zhao, Division of Pharmacometrics, CDER), industry (presented by Dr. Neil Parrott, Hoffman-La Roche, representing industry PBPK working group), and academia (Dr. Malcolm Rowland, University of Manchester, UK).
